$MFIN
MEDALLION FINANCIAL CORP Stock $mfin

$mfin Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000095017024054668 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$70.70M	$67.07M
YoY Change	14.54%	20.1%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.336M	$1.381M
YoY Change	7.92%	6.23%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$20.84M	$19.15M
YoY Change	38.58%	56.48%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$12.40M	$17.89M
YoY Change	-41.41%	-23.05%
Income Tax	$3.782M	$6.358M
% Of Pretax Income	30.51%	35.53%
Net Earnings	$7.101M	$10.02M
YoY Change	-49.89%	-34.74%
Net Earnings / Revenue	10.04%	14.95%
Basic Earnings Per Share	$0.31	$0.44
Diluted Earnings Per Share	$0.30	$0.42
COMMON SHARES
Basic Shares Outstanding	23.38M	23.48M
Diluted Shares Outstanding	23.45M	23.77M

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$143.5M	$107.8M
YoY Change	5.59%	55.56%
Cash & Equivalents	$87.72M	$54.78M
Short-Term Investments	$55.83M	$53.04M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$14.09M	$14.02M
YoY Change	5.63%	4.65%
Goodwill	$150.8M	$150.8M
YoY Change	0.0%	0.0%
Intangibles	$19.87M	$20.23M
YoY Change	-6.78%	-6.67%
Long-Term Investments	$66.63M	$69.41M
YoY Change	2.35%	551.57%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.761B	$2.619B
YoY Change	9.6%	11.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$34.54M	$32.26M
YoY Change	-6.94%	10.67%
Accrued Expenses	$6.071M	$6.710M
YoY Change	-20.42%	-35.37%
Deferred Revenue
YoY Change
Short-Term Debt	$37.50M	$32.50M
YoY Change	-44.76%	-15.58%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$78.11M	$71.47M
YoY Change	-30.64%	-9.7%
LONG-TERM LIABILITIES
Long-Term Debt	$230.8M	$225.6M
YoY Change	29.57%	28.26%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$230.8M	$225.6M
YoY Change	29.57%	28.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$78.11M	$71.47M
Total Long-Term Liabilities	$230.8M	$225.6M
Total Liabilities	$2.407B	$2.270B
YoY Change	9.4%	14.83%
SHAREHOLDERS EQUITY
Retained Earnings	$116.3M	$111.6M
YoY Change	40.94%	58.85%
Common Stock	$290.6M	$289.0M
YoY Change	1.7%	1.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$49.18M	$47.66M
YoY Change	8.0%	4.67%
Treasury Stock Shares
Shareholders Equity	$354.0M	$349.0M
YoY Change
Total Liabilities & Shareholders Equity	$2.761B	$2.619B
YoY Change	9.6%	11.36%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$7.101M	$10.02M
YoY Change	-49.89%	-34.74%
Depreciation, Depletion And Amortization	$1.336M	$1.381M
YoY Change	7.92%	6.23%
Cash From Operating Activities	$27.64M	$32.26M
YoY Change	-5.19%	10.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$171.6M	-$32.91M
YoY Change	-6.68%	-59.6%
Cash From Investing Activities	-$171.6M	-$32.91M
YoY Change	-6.68%	-59.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	132.8M	19.93M
YoY Change	-9.6%	-74.8%
NET CHANGE
Cash From Operating Activities	27.64M	32.26M
Cash From Investing Activities	-171.6M	-32.91M
Cash From Financing Activities	132.8M	19.93M
Net Change In Cash	-11.16M	19.28M
YoY Change	42.62%	-28.02%
FREE CASH FLOW
Cash From Operating Activities	$27.64M	$32.26M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001000209
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#EquitySecuritiesMember
CY2023	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2033-12-21
CY2023Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2028-09-30
CY2021Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2026-02-28
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.medallion.com/20240331#PropertyEquipmentAndRightOfUseAssetNet
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.medallion.com/20240331#PropertyEquipmentAndRightOfUseAssetNet
CY2024Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-37747
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	MEDALLION FINANCIAL CORP
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3291176
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	437 MADISON AVENUE, 38th Floor
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	NEW YORK
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2024Q1	dei	City Area Code CityAreaCode	212
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	328-2100
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	MFIN
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23376542
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54778000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52591000
CY2024Q1	us-gaap	Federal Funds Sold FederalFundsSold	114347000
CY2023Q4	us-gaap	Federal Funds Sold FederalFundsSold	97254000
CY2024Q1	us-gaap	Marketable Securities MarketableSecurities	53038000
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	54282000
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	16374000
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	11430000
CY2024Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2228426000
CY2023Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2215886000
CY2024Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	83827000
CY2023Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	84235000
CY2024Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	2144599000
CY2023Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	2131651000
CY2024Q1	us-gaap	Goodwill Goodwill	150803000
CY2023Q4	us-gaap	Goodwill Goodwill	150803000
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20230000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20591000
CY2024Q1	mfin	Property Equipment And Right Of Use Asset Net PropertyEquipmentAndRightOfUseAssetNet	14024000
CY2023Q4	mfin	Property Equipment And Right Of Use Asset Net PropertyEquipmentAndRightOfUseAssetNet	14076000
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	12673000
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	13538000
CY2024Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	10198000
CY2023Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	11772000
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	671000
CY2024Q1	us-gaap	Other Assets OtherAssets	27698000
CY2023Q4	us-gaap	Other Assets OtherAssets	29168000
CY2024Q1	us-gaap	Assets Assets	2618762000
CY2023Q4	us-gaap	Assets Assets	2587827000
CY2024Q1	us-gaap	Deposits Deposits	1879061000
CY2023Q4	us-gaap	Deposits Deposits	1866657000
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	225558000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	235544000
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	32500000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	8000000
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	24846000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	21207000
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6710000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7019000
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6077000
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6822000
CY2024Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	1980000
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	24206000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	30804000
CY2024Q1	us-gaap	Liabilities Liabilities	2200938000
CY2023Q4	us-gaap	Liabilities Liabilities	2176053000
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29243878
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29051800
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	292000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	291000
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	288685000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	288046000
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5866314
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5602154
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	47664000
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	45538000
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3846000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3696000
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	111569000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	103883000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	349036000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	342986000
CY2024Q1	us-gaap	Minority Interest MinorityInterest	68788000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	68788000
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	417824000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	411774000
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2618762000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2587827000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23377564
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23449646
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.93
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.63
CY2024Q1	mfin	Loan Foreclosure Collateral Sale To Third Party LoanForeclosureCollateralSaleToThirdParty	5800000
CY2023Q4	mfin	Loan Foreclosure Collateral Sale To Third Party LoanForeclosureCollateralSaleToThirdParty	6200000
CY2024Q1	mfin	Short Term Lease Liabilities ShortTermLeaseLiabilities	2300000
CY2023Q4	mfin	Short Term Lease Liabilities ShortTermLeaseLiabilities	2500000
CY2024Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	65221000
CY2023Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	55169000
CY2024Q1	mfin	Interest And Dividends On Investment Securities InterestAndDividendsOnInvestmentSecurities	1849000
CY2023Q1	mfin	Interest And Dividends On Investment Securities InterestAndDividendsOnInvestmentSecurities	674000
CY2024Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	67070000
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	55843000
CY2024Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	14752000
CY2023Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	8599000
CY2024Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	4255000
CY2023Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	2853000
CY2024Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	146000
CY2023Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	788000
CY2024Q1	us-gaap	Interest Expense InterestExpense	19153000
CY2023Q1	us-gaap	Interest Expense InterestExpense	12240000
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	47917000
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	43603000
CY2024Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	17201000
CY2023Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4038000
CY2024Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	30716000
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	39565000
CY2024Q1	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	4167000
CY2023Q1	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-90000
CY2024Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	588000
CY2023Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1855000
CY2024Q1	mfin	Writedown Of Loan Collateral In Process Of Foreclosure WritedownOfLoanCollateralInProcessOfForeclosure	0
CY2023Q1	mfin	Writedown Of Loan Collateral In Process Of Foreclosure WritedownOfLoanCollateralInProcessOfForeclosure	252000
CY2024Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	648000
CY2023Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	570000
CY2024Q1	us-gaap	Noninterest Income NoninterestIncome	5403000
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	2083000
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	9457000
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8836000
CY2024Q1	mfin	Loan Servicing Fee LoanServicingFee	2470000
CY2023Q1	mfin	Loan Servicing Fee LoanServicingFee	2222000
CY2024Q1	mfin	Collection Costs CollectionCosts	1467000
CY2023Q1	mfin	Collection Costs CollectionCosts	1538000
CY2024Q1	mfin	Regulatory Fees RegulatoryFees	977000
CY2023Q1	mfin	Regulatory Fees RegulatoryFees	682000
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	771000
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	1707000
CY2024Q1	mfin	Lease And Rental Expense1 LeaseAndRentalExpense1	657000
CY2023Q1	mfin	Lease And Rental Expense1 LeaseAndRentalExpense1	623000
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	361000
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	360000
CY2024Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2065000
CY2023Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2425000
CY2024Q1	us-gaap	Noninterest Expense NoninterestExpense	18225000
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	18393000
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17894000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23255000
CY2024Q1	mfin	Income Tax Expense Benefit On Net Investment IncomeTaxExpenseBenefitOnNetInvestment	6358000
CY2023Q1	mfin	Income Tax Expense Benefit On Net Investment IncomeTaxExpenseBenefitOnNetInvestment	6382000
CY2024Q1	mfin	Net Investment Income Loss After Taxes NetInvestmentIncomeLossAfterTaxes	11536000
CY2023Q1	mfin	Net Investment Income Loss After Taxes NetInvestmentIncomeLossAfterTaxes	16873000
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1512000
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1512000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	10024000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	15361000
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22641385
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22342911
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23765045
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22975457
CY2024Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	600000
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	300000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	11536000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	16873000
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-150000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	506000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	11386000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	17379000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1512000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1512000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9874000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15867000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	411774000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	11536000
CY2024Q1	mfin	Distribution To Noncontrolling Interest DistributionToNoncontrollingInterest	-1512000
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1496000
CY2024Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-944000
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	88000
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2126000
CY2024Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.1
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2338000
CY2024Q1	mfin	Net Change In Unrealized Gains Losses Net Of Tax NetChangeInUnrealizedGainsLossesNetOfTax	-150000
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	417824000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	370524000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	16873000
CY2023Q1	mfin	Distribution To Noncontrolling Interest DistributionToNoncontrollingInterest	-1512000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1036000
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-768000
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	292000
CY2023Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.08
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1863000
CY2023Q1	mfin	Net Change In Unrealized Gains Losses Net Of Tax NetChangeInUnrealizedGainsLossesNetOfTax	506000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	375153000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	11536000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	16873000
CY2024Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	17201000
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	4038000
CY2024Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	608000
CY2023Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	264000
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1381000
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1300000
CY2024Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-2007000
CY2023Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-2173000
CY2024Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	6290000
CY2023Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	6437000
CY2024Q1	mfin	Net Change In Loan Collateral In Process Of Foreclosure NetChangeInLoanCollateralInProcessOfForeclosure	-3240000
CY2023Q1	mfin	Net Change In Loan Collateral In Process Of Foreclosure NetChangeInLoanCollateralInProcessOfForeclosure	-2330000
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	4167000
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-90000
CY2024Q1	mfin	Net Change In Unrealized Appreciation On Other Investments NetChangeInUnrealizedAppreciationOnOtherInvestments	0
CY2023Q1	mfin	Net Change In Unrealized Appreciation On Other Investments NetChangeInUnrealizedAppreciationOnOtherInvestments	28000
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1496000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1036000
CY2024Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-865000
CY2023Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-378000
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-522000
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8605000
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6763000
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4120000
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-745000
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-751000
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32255000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	29127000
CY2024Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	175721000
CY2023Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	230846000
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	138748000
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	143891000
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	795000
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	450000
CY2024Q1	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	1103000
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	438000
CY2024Q1	mfin	Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure	3759000
CY2023Q1	mfin	Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure	5526000
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32906000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-81441000
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	212807000
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	240056000
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	185900000
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	157100000
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2482000
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1870000
CY2024Q1	mfin	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	1512000
CY2023Q1	mfin	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	1512000
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	944000
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	768000
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2126000
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	88000
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	292000
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19931000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	79098000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19280000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	26784000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	149845000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	105598000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	169125000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	132382000
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	18976000
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	12372000
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10000
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	143000
CY2024Q1	mfin	Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure	5425000
CY2023Q1	mfin	Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure	6504000
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S., or GAAP, requires management to make estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. Accounting estimates and assumptions are those that management considers to be the most critical to an understanding of the consolidated financial statements because they inherently involve significant judgments and uncertainties. All of these estimates reflect management’s best judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions change, it is reasonably possible that the judgments and estimates could change, which may result in future impairments of loans and loan collateral in process of foreclosure, goodwill and intangible assets, and investments, among other effects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	1300000
CY2024Q1	mfin	Non Marketable Securities NonMarketableSecurities	16400000
CY2023Q4	mfin	Non Marketable Securities NonMarketableSecurities	11400000
CY2024Q1	mfin	Cumulative Appreciation Of Equity Investments CumulativeAppreciationOfEquityInvestments	4700000
CY2024Q1	mfin	Impact Of Equity Investment ImpactOfEquityInvestment	4000000
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2000000
CY2024Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1700000
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1700000
CY2024Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-19000
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	28000
CY2024Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0
CY2023Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0
CY2024Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-19000
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	28000
CY2024Q1	mfin	Deferred Loan Origination Costs DeferredLoanOriginationCosts	40700000
CY2023	mfin	Deferred Loan Origination Costs DeferredLoanOriginationCosts	40000000
CY2024Q1	mfin	Amortization Of Loan Origination Fees Net AmortizationOfLoanOriginationFeesNet	2000000
CY2023Q1	mfin	Amortization Of Loan Origination Fees Net AmortizationOfLoanOriginationFeesNet	1900000
CY2023Q1	mfin	Loans Charged Off LoansChargedOff	2500000
CY2024Q1	us-gaap	Notes Receivable Net NotesReceivableNet	79500
CY2024Q1	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	14000000
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	14000000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	63845000
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2024Q1	us-gaap	Goodwill Goodwill	150800000
CY2023Q4	us-gaap	Goodwill Goodwill	150800000
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20200000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20600000
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20230000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20591000
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100000
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100000
CY2024Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	800000
CY2023Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	800000
CY2024Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	8500000
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	8500000
CY2024Q1	mfin	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	10024000
CY2023Q1	mfin	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	15361000
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22641385
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22342911
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	610333
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	483429
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	254793
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	149117
CY2024Q1	mfin	Incremental Common Shares Attributable To Dilutive Effect Of Performance Share Units IncrementalCommonSharesAttributableToDilutiveEffectOfPerformanceShareUnits	258534
CY2023Q1	mfin	Incremental Common Shares Attributable To Dilutive Effect Of Performance Share Units IncrementalCommonSharesAttributableToDilutiveEffectOfPerformanceShareUnits	0
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23765045
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22975457
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9000
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9000
CY2024Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1500000
CY2024Q1	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	0.06
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1000000
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	0.05
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	9300000
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P12M
CY2024Q1	mfin	Tier One Leverage Capital Required For Capital Adequacy To Total Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToTotalAssets	0.15
CY2024Q1	mfin	Tier One Leverage Capital Ratio TierOneLeverageCapitalRatio	0.164
CY2024Q1	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	298662000
CY2023Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	293774000
CY2024Q1	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	367450000
CY2023Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	362561000
CY2024Q1	us-gaap	Capital Capital	395297000
CY2023Q4	us-gaap	Capital Capital	390153000
CY2024Q1	mfin	Average Assets AverageAssets	2236357000
CY2023	mfin	Average Assets AverageAssets	2232816000
CY2024Q1	us-gaap	Risk Weighted Assets RiskWeightedAssets	2176939000
CY2023Q4	us-gaap	Risk Weighted Assets RiskWeightedAssets	2155641000
CY2024Q1	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.04
CY2024Q1	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.05
CY2024Q1	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.164
CY2023Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.162
CY2024Q1	mfin	Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.07
CY2024Q1	mfin	Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.065
CY2024Q1	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.137
CY2023Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.136
CY2024Q1	mfin	Tier One Risk Based Capital Required For Capital Adequacy With Buffer To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyWithBufferToRiskWeightedAssets	0.085
CY2024Q1	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.08
CY2024Q1	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.169
CY2023Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.168
CY2024Q1	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.105
CY2024Q1	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.10
CY2024Q1	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.182
CY2023Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.181
CY2024Q1	mfin	Tier One Capital Conversation Buffer TierOneCapitalConversationBuffer	0.025
CY2023	mfin	Tier One Capital Conversation Buffer TierOneCapitalConversationBuffer	0.025
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to prior year balances to conform with the current year presentation. These reclassifications have no effect on the previously reported results of operations.</span></p>
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	59539000
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13000
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6514000
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	53038000
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	60573000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	21000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6312000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	54282000
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	3970000
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	3886000
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	5885000
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5662000
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	8484000
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	7414000
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	41200000
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	36076000
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	59539000
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	53038000
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	40000
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	1916000
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	6474000
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	50990000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	282000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	10636000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	6030000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	43509000
CY2023Q4	mfin	Number Of Securities NumberOfSecurities	60
CY2024Q1	mfin	Number Of Securities NumberOfSecurities	60
CY2023Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	84235000
CY2022Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	63845000
CY2024Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	22999000
CY2023Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	18097000
CY2024Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	5390000
CY2023Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	6782000
CY2024Q1	us-gaap	Allowance For Loan And Lease Losses Writeoffs Net AllowanceForLoanAndLeaseLossesWriteoffsNet	17609000
CY2023Q1	us-gaap	Allowance For Loan And Lease Losses Writeoffs Net AllowanceForLoanAndLeaseLossesWriteoffsNet	11315000
CY2024Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	17201000
CY2023Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4038000
CY2024Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	83827000
CY2023Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	70280000
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff	0
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	5287000
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	8498000
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	4660000
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff	1576000
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff	2978000
CY2024Q1	mfin	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Write Off1 FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteOff1	22999000
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff	0
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	4512000
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	3698000
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	1814000
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff	1685000
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff	6388000
CY2023Q1	mfin	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Write Off1 FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteOff1	18097000
CY2024Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	83827000
CY2024Q1	mfin	Percentage Of Allowance For Loan Losses PercentageOfAllowanceForLoanLosses	1
CY2024Q1	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans	0.0376
CY2024Q1	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual	3.831
CY2023Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	84235000
CY2023Q4	mfin	Percentage Of Allowance For Loan Losses PercentageOfAllowanceForLoanLosses	1
CY2023Q4	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans	0.038
CY2023Q4	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual	3.2431
CY2023Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	2176412000
CY2023Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0
CY2023	mfin	Capitalized Loan Origination Costs CapitalizedLoanOriginationCosts	40000000
CY2024Q1	mfin	Loan To Value Ratio LoanToValueRatio	1.88
CY2023Q4	mfin	Loan To Value Ratio LoanToValueRatio	1.83
CY2023Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	11772000
CY2024Q1	mfin	Loan In Process Of Foreclosure Loans Transfer LoanInProcessOfForeclosureLoansTransfer	5425000
CY2024Q1	mfin	Loan In Process Of Foreclosure Loan Sales LoanInProcessOfForeclosureLoanSales	-39000
CY2024Q1	mfin	Loan In Process Of Foreclosure Loans Cash Payment Received LoanInProcessOfForeclosureLoansCashPaymentReceived	-3720000
CY2024Q1	us-gaap	Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest	21881000
CY2023Q4	us-gaap	Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest	25974000
CY2024Q1	mfin	Interest Foregone Quarter To Date InterestForegoneQuarterToDate	309000
CY2023	mfin	Interest Foregone Quarter To Date InterestForegoneQuarterToDate	928000
CY2024Q1	mfin	Amount Of Foregone Interest Applied To Principal In The Quarter AmountOfForegoneInterestAppliedToPrincipalInTheQuarter	64000
CY2023	mfin	Amount Of Foregone Interest Applied To Principal In The Quarter AmountOfForegoneInterestAppliedToPrincipalInTheQuarter	238000
CY2024Q1	mfin	Interest Foregone Life To Date InterestForegoneLifeToDate	1101000
CY2023	mfin	Interest Foregone Life To Date InterestForegoneLifeToDate	2119000
CY2024Q1	mfin	Amount Of Foregone Interest Applied To Principal Life To Date AmountOfForegoneInterestAppliedToPrincipalLifeToDate	816000
CY2023	mfin	Amount Of Foregone Interest Applied To Principal Life To Date AmountOfForegoneInterestAppliedToPrincipalLifeToDate	822000
CY2024Q1	us-gaap	Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans	0.01
CY2023Q4	us-gaap	Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans	0.012
CY2024Q1	mfin	Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans	3.831
CY2023Q4	mfin	Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans	3.243
CY2024Q1	us-gaap	Loans And Leases Receivable Loans In Process LoansAndLeasesReceivableLoansInProcess	2228426000
CY2024Q1	mfin	Loans And Leases Receivable Non Performing Percentage LoansAndLeasesReceivableNonPerformingPercentage	0.0098
CY2023Q4	us-gaap	Loans And Leases Receivable Loans In Process LoansAndLeasesReceivableLoansInProcess	2215886000
CY2023	mfin	Loans And Leases Receivable Non Performing Percentage LoansAndLeasesReceivableNonPerformingPercentage	0.0117
CY2024Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	21881000
CY2024Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	22697000
CY2024Q1	mfin	Impaired Financing Receivables With Related Allowance Related Allowance ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance	4156000
CY2023Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	25974000
CY2023Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	26796000
CY2023Q4	mfin	Impaired Financing Receivables With Related Allowance Related Allowance ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance	3890000
CY2024Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	22581000
CY2024Q1	mfin	Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod	17000
CY2023Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	16842000
CY2023Q1	mfin	Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod	14000
CY2024Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	70517000
CY2024Q1	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	2188640000
CY2024Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0
CY2024Q1	mfin	Capitalized Loan Origination Costs CapitalizedLoanOriginationCosts	40700000
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	81013000
CY2024Q1	mfin	Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments LoanInProcessOfForeclosureLoansCollateralValuationAdjustments	-3240000
CY2024Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	10198000
CY2022Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	21819000
CY2023Q1	mfin	Loan In Process Of Foreclosure Loans Transfer LoanInProcessOfForeclosureLoansTransfer	6504000
CY2023Q1	mfin	Loan In Process Of Foreclosure Loan Sales LoanInProcessOfForeclosureLoanSales	-2210000
CY2023Q1	mfin	Loan In Process Of Foreclosure Loans Cash Payment Received LoanInProcessOfForeclosureLoansCashPaymentReceived	-3317000
CY2023Q1	mfin	Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments LoanInProcessOfForeclosureLoansCollateralValuationAdjustments	-2329000
CY2023Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	20467000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	753655000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	526332000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	354570000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	211550000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	214739000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	83250000
CY2024Q1	mfin	Debt Long Term And Short Term Funds Borrowed Amount DebtLongTermAndShortTermFundsBorrowedAmount	2144096000
CY2023Q4	mfin	Debt Long Term And Short Term Funds Borrowed Amount DebtLongTermAndShortTermFundsBorrowedAmount	2117189000
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0359
CY2024Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	8500000
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	8500000
CY2024Q1	mfin	Reserve Deposits ReserveDeposits	1500000
CY2023Q4	mfin	Reserve Deposits ReserveDeposits	1500000
CY2024Q1	mfin	Listing Services Deposits From Other Financial Institutions ListingServicesDepositsFromOtherFinancialInstitutions	12100000
CY2023Q4	mfin	Listing Services Deposits From Other Financial Institutions ListingServicesDepositsFromOtherFinancialInstitutions	11800000
CY2024Q1	us-gaap	Deposits Retail DepositsRetail	12400000
CY2023Q4	us-gaap	Deposits Retail DepositsRetail	14900000
CY2024Q1	us-gaap	Contractual Maturities Time Deposits100000 Or More Three Months Or Less ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsOrLess	202913000
CY2024Q1	us-gaap	Contractual Maturities Time Deposits100000 Or More Three Months Through Six Months ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsThroughSixMonths	186507000
CY2024Q1	us-gaap	Contractual Maturities Time Deposits100000 Or More Six Months Through12 Months ContractualMaturitiesTimeDeposits100000OrMoreSixMonthsThrough12Months	331735000
CY2024Q1	us-gaap	Contractual Maturities Time Deposits100000 Or More After12 Months ContractualMaturitiesTimeDeposits100000OrMoreAfter12Months	1160691000
CY2024Q1	us-gaap	Time Deposits100000 Or More TimeDeposits100000OrMore	1881846000
CY2024Q1	mfin	Collateral Deposits CollateralDeposits	1500000
CY2024Q1	us-gaap	Time Deposits TimeDeposits	1883346000
CY2019Q3	us-gaap	Notes Payable NotesPayable	6000000
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3000000
CY2007Q4	us-gaap	Payments For Repurchase Of Trust Preferred Securities PaymentsForRepurchaseOfTrustPreferredSecurities	2000000
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	604000
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	597000
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	657000
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	623000
CY2024Q1	mfin	Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	-59000
CY2023Q1	mfin	Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	-56000
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8327000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8785000
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2255000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2472000
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6710000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7019000
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8965000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9491000
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M24D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0556
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0547
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1903000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2546000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2567000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1342000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	573000
CY2024Q1	mfin	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1139000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10070000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1105000
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8965000
CY2024Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	42943000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	43034000
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	12005000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	13032000
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3803000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3802000
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	4794000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	6976000
CY2024Q1	mfin	Deferred Tax Liabilities Unrealized Loss On Other Investments DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments	-868000
CY2023Q4	mfin	Deferred Tax Liabilities Unrealized Loss On Other Investments DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments	-1877000
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	21473000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	17347000
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3373000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3860000
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	24846000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	21207000
CY2024Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1729000
CY2023Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2583000
CY2024Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	643000
CY2023Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	789000
CY2024Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3116000
CY2023Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2246000
CY2024Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	870000
CY2023Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	764000
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6358000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6382000
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.61
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2024Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3758000
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4884000
CY2024Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	735000
CY2023Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	955000
CY2024Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1780000
CY2023Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1058000
CY2024Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-85000
CY2023Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	515000
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6358000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6382000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	946054
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	857609
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1061849
CY2022Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit	2.14
CY2022Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit	9.38
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.51
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023	mfin	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	33382
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.8
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	68945
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.44
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	959522
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit	2.14
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit	9.38
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.51
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2024Q1	mfin	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	85
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	4.89
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	13383
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	946054
CY2024Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit	2.14
CY2024Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit	9.38
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.51
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	697647
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit	2.14
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit	9.38
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.51
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	857609
CY2024Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit	2.14
CY2024Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit	9.38
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.52
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1300000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1200000
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y9M18D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	261875
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit	4.89
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit	7.25
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	6.49
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	173430
CY2024Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeLowerRangeLimit	4.89
CY2024Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeUpperRangeLimit	7.25
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	6.56
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	88445
CY2024Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit	4.89
CY2024Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit	7.25
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	6.37
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	400000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	162615
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	5
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2024Q1	mfin	Number Of Non Operating Segments NumberOfNonOperatingSegments	1
CY2024Q1	mfin	Interest Income Expense Operating InterestIncomeExpenseOperating	67070000
CY2024Q1	mfin	Interest Expense Net InterestExpenseNet	19153000
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	47917000
CY2024Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	17201000
CY2024Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	30716000
CY2024Q1	us-gaap	Other Income OtherIncome	5403000
CY2024Q1	us-gaap	Noninterest Expense NoninterestExpense	18225000
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17894000
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6358000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	11536000
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1512000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	10024000
CY2024Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2228426000
CY2024Q1	us-gaap	Assets Assets	2618762000
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	2145596000
CY2024Q1	mfin	Return On Average Assets Percentage ReturnOnAverageAssetsPercentage	0.018
CY2024Q1	mfin	Percentage Of Return On Average Stockholders Equity PercentageOfReturnOnAverageStockholdersEquity	0.1165
CY2024Q1	mfin	Percentage Of Return On Average Equity PercentageOfReturnOnAverageEquity	0.1118
CY2024Q1	mfin	Interest Yield InterestYield	0.1134
CY2024Q1	mfin	Net Interest Margin NetInterestMargin	0.081
CY2024Q1	mfin	Net Interest Margin Net Of Allowance Percentage NetInterestMarginNetOfAllowancePercentage	0.0839
CY2024Q1	mfin	Reserve Coverage Ratio ReserveCoverageRatio	0.0376
CY2024Q1	mfin	Delinquency Status DelinquencyStatus	0.0074
CY2024Q1	mfin	Chargeoffs To Loans Percentage ChargeoffsToLoansPercentage	0.032
CY2023Q1	mfin	Interest Income Expense Operating InterestIncomeExpenseOperating	55843000
CY2023Q1	mfin	Interest Expense Net InterestExpenseNet	12240000
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	43603000
CY2023Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4038000
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	39565000
CY2023Q1	us-gaap	Other Income OtherIncome	2083000
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	18393000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23255000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6382000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	16873000
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1512000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	15361000
CY2023Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1984180000
CY2023Q1	us-gaap	Assets Assets	2351670000
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1916390000
CY2023Q1	mfin	Return On Average Assets Percentage ReturnOnAverageAssetsPercentage	0.0299
CY2023Q1	mfin	Percentage Of Return On Average Stockholders Equity PercentageOfReturnOnAverageStockholdersEquity	0.2072
CY2023Q1	mfin	Percentage Of Return On Average Equity PercentageOfReturnOnAverageEquity	0.185
CY2023Q1	mfin	Interest Yield InterestYield	0.1078
CY2023Q1	mfin	Net Interest Margin NetInterestMargin	0.0842
CY2023Q1	mfin	Net Interest Margin Net Of Allowance Percentage NetInterestMarginNetOfAllowancePercentage	0.0871
CY2023Q1	mfin	Reserve Coverage Ratio ReserveCoverageRatio	0.0354
CY2023Q1	mfin	Delinquency Status DelinquencyStatus	0.0024
CY2023Q1	mfin	Chargeoffs To Loans Percentage ChargeoffsToLoansPercentage	0.0235
CY2024Q1	mfin	Employment Agreement Description EmploymentAgreementDescription	employment agreements expire at various dates through 2027
CY2024Q1	mfin	Employment Agreements Future Minimum Payments Due EmploymentAgreementsFutureMinimumPaymentsDue	9900000
CY2024Q1	us-gaap	Other Commitment OtherCommitment	0
CY2024Q1	mfin	Net Change In Unrealized Gains Losses Net Of Tax NetChangeInUnrealizedGainsLossesNetOfTax	-200000
CY2023	mfin	Net Change In Unrealized Gains Losses Net Of Tax NetChangeInUnrealizedGainsLossesNetOfTax	-300000
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	mfin	Rule10 B51 Arr Modified Flag Rule10B51ArrModifiedFlag	false
CY2024Q1	mfin	Non Rule10 B51 Arr Modified Flag NonRule10B51ArrModifiedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000950170-24-054668-index-headers.html	Edgar Link	pending
0000950170-24-054668-index.html	Edgar Link	pending
0000950170-24-054668.txt	Edgar Link	pending
0000950170-24-054668-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mfin-20240331.htm	Edgar Link	pending
mfin-20240331.xsd	Edgar Link	pending
mfin-ex31_1.htm	Edgar Link	pending
mfin-ex31_2.htm	Edgar Link	pending
mfin-ex32_1.htm	Edgar Link	pending
mfin-ex32_2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
mfin-20240331_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MFIN
MEDALLION FINANCIAL CORP Stock $mfin

2024 Q2 Form 10-Q Financial Statement

#000095017024054668 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MFIN MEDALLION FINANCIAL CORP Stock $mfin

2024 Q2 Form 10-Q Financial Statement

#000095017024054668 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MFIN
MEDALLION FINANCIAL CORP Stock $mfin